Radiopharmaceutical Leader ITM Gets A Burst Of Energy – And Weighs Up Going Public

ITM is reaping benefits from long-term investment in radiopharmaceuticals manufacturing and is now looking to challenge its customer, Novartis, by bringing its first product to market.